Hypothalamic Neoplasms

2

Review clinical trials related to Hypothalamic Neoplasms. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm

The goal of this observational study is to learn about the treatment strategies for tumor in sellar region with unruptured intracranial aneurysms in the Chinese population. The main question it aims to answer is: For patients with tumor in sellar region combined with unruptured intracranial aneurysms, which condition should be treated first?

Participants needed: 608
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: Cheng senUpdated: Sep 9, 2026Locations: 1Duration: 2 Years
Eligibility criteria

Preoperative enhanced head MRI showing a suspected diagnosis of a sella region l... [+4]

Patients with recurrent sella region tumors. [+3]

Status: Recruiting

KETO-TUMOR: a Study on Brain Tumors and Central Obesity

Hypothalamic-chiasmatic tumours account for 5-10% of CNS tumours in children and can compromise hypothalamic function, causing alterations in energy balance and weight gain. In inoperable cases, chemotherapy and radiotherapy are used; the latter, although the gold standard, is associated with significant neurocognitive and endocrine-metabolic side effects, proportional to the hypothalamic damage. The ketogenic diet, used for decades in the treatment of drug-resistant childhood epilepsy, induces the use of ketone bodies as a source of energy for the brain and is effective in controlling seizures. Among the different variants, the modified Atkins diet was chosen in this study to promote better patient adherence. This study aims to evaluate the effectiveness of the ketogenic diet (KD) in treating central obesity secondary to hypothalamic-chiasmatic tumours (gliomas, craniopharyngiomas, germ cell tumours, etc.), which often lead to excessive weight gain. This is refractory to drug therapy and lifestyle changes, such as low-calorie diets and exercise.

Participants needed: 30
Trial details
Age: 7-30Biological sex: AllType: InterventionalSponsor: Meyer Children's Hospital IRCCSUpdated: Feb 9, 2026Locations: 1
Eligibility criteria

Diagnosis of hypothalamic-chiasmatic tumour according to the WHO 2021 classifica... [+5]

Primary carnitine [+9]